26038205 24943299 33796077 30753137 28747387 34771744 24758183 33775861 35197862 32411097 28261922 24087794 24399884 24472523 24446485 34313632 26765578 28604387 27445978 23402683 25906099 23426162 27282482 23778974 32783015 30605778 24274318 2612474 - Search Results

Year	Number of Results
2012	3
2013	19
2014	14
2015	21
2016	16
2017	9
2018	9
2019	8
2020	8
2021	10
2022	4

1

Primary aldosteronism: challenges in diagnosis and management.

Galati SJ. Galati SJ. Endocrinol Metab Clin North Am. 2015 Jun;44(2):355-69. doi: 10.1016/j.ecl.2015.02.010. Endocrinol Metab Clin North Am. 2015. PMID: 26038205 Review.

2

Genetics of primary aldosteronism.

Funder JW. Funder JW. Front Horm Res. 2014;43:70-8. doi: 10.1159/000360870. Epub 2014 Jun 10. Front Horm Res. 2014. PMID: 24943299

3

Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations.

Lim JS, Plaska SW, Rege J, Rainey WE, Turcu AF. Lim JS, et al. Front Endocrinol (Lausanne). 2021 Mar 16;12:644382. doi: 10.3389/fendo.2021.644382. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33796077 Free PMC article.

4

Genetics of aldosterone-producing adenomas with pathogenic KCNJ5 variants.

Lerario AM, Nanba K, Blinder AR, Suematsu S, Omura M, Nishikawa T, Giordano TJ, Rainey WE, Else T. Lerario AM, et al. Endocr Relat Cancer. 2019 Apr 1;26(4):463-470. doi: 10.1530/ERC-18-0364. Epub 2019 Feb 1. Endocr Relat Cancer. 2019. PMID: 30753137 Free PMC article.

5

Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas.

Murakami M, Yoshimoto T, Nakabayashi K, Nakano Y, Fukaishi T, Tsuchiya K, Minami I, Bouchi R, Okamura K, Fujii Y, Hashimoto K, Hata KI, Kihara K, Ogawa Y. Murakami M, et al. Endocr Relat Cancer. 2017 Oct;24(10):531-541. doi: 10.1530/ERC-17-0117. Epub 2017 Jul 26. Endocr Relat Cancer. 2017. PMID: 28747387

6

Transcriptomics, Epigenetics, and Metabolomics of Primary Aldosteronism.

Spyroglou A, Piaditis GP, Kaltsas G, Alexandraki KI. Spyroglou A, et al. Cancers (Basel). 2021 Nov 8;13(21):5582. doi: 10.3390/cancers13215582. Cancers (Basel). 2021. PMID: 34771744 Free PMC article. Review.

7

Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?

Dekkers T, ter Meer M, Lenders JW, Hermus AR, Schultze Kool L, Langenhuijsen JF, Nishimoto K, Ogishima T, Mukai K, Azizan EA, Tops B, Deinum J, Küsters B. Dekkers T, et al. J Clin Endocrinol Metab. 2014 Jul;99(7):E1341-51. doi: 10.1210/jc.2013-4255. Epub 2014 Apr 23. J Clin Endocrinol Metab. 2014. PMID: 24758183

8

Primary aldosteronism.

Funder J. Funder J. Trends Cardiovasc Med. 2022 May;32(4):228-233. doi: 10.1016/j.tcm.2021.03.005. Epub 2021 Mar 26. Trends Cardiovasc Med. 2022. PMID: 33775861 Review.

9

Aldosterone-Regulated Sodium Transport and Blood Pressure.

Tsilosani A, Gao C, Zhang W. Tsilosani A, et al. Front Physiol. 2022 Feb 7;13:770375. doi: 10.3389/fphys.2022.770375. eCollection 2022. Front Physiol. 2022. PMID: 35197862 Free PMC article. Review.

10

The Effects of Different Calcium Channel Blockers on Aldosterone-Producing Adenoma Cells.

Wang F, Ma X, Tong A, Zhang Y, Wen J, Li Y. Wang F, et al. Front Endocrinol (Lausanne). 2020 Apr 28;11:260. doi: 10.3389/fendo.2020.00260. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32411097 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results